Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "AI in Remote Patient Monitoring Market 2025-2029" has been added to ResearchAndMarkets.com's offering.
The AI in remote patient monitoring market is poised for significant growth, with projections estimating an increase of USD 5.00 billion from 2024 to 2029. The market is expected to accelerate with a compound annual growth rate (CAGR) of 27.6% during this period. A comprehensive report offers a thorough analysis, detailing market size, trends, growth drivers, challenges, and vendor activities, covering approximately 25 key industry players.
The market's expansion is driven by several factors: aging global demographics and the resulting rise in chronic conditions, rapid advancements in artificial intelligence and sensor technologies, and a systemic transition towards value-oriented reimbursement models in healthcare cost management.
The research methodology involved a combination of primary and secondary sources, supplemented by insights from industry participants. The report includes comprehensive data on market size and segmentation, examining regional impacts and vendor landscapes alongside key company analysis. Historical and forecast data have been integrated for a complete market overview.
Market Segmentation:
- By Component: Solutions, Services
- By Indication: Cardiology, Diabetes, Neurology, Oncology, Others
- By End-user: Hospitals, Home healthcare providers, Outpatient clinics, Others
- By Geographical Landscape: North America, Europe, APAC, South America, Middle East and Africa
Key market growth drivers include the implementation of hyper-personalization through predictive analytics and digital twins, and the expansion into novel therapeutic areas outside traditional chronic diseases. The integration of generative AI and conversational interfaces is anticipated to enhance engagement and increase market demand.
The report covers the following areas:
- Market sizing and forecasting
- Industry analysis
- Vendor analysis
The vendor analysis aims to aid clients in enhancing their market stance, featuring detailed insights on prominent vendors including AMC Health, Apple Inc., Biofourmis Inc., Boston Scientific Corp., and several others. The report also addresses emerging trends and challenges that may impact market growth, helping companies strategize to capitalize on forthcoming opportunities.
This market report synthesizes and summarizes data from multiple sources, offering a detailed market narrative based on key parameters such as profitability, pricing, competition, and promotions. Presenting a comprehensive view, it leverages both qualitative and quantitative research to deliver precise market growth forecasts, alongside an extensive competitive landscape and vendor selection process.
Key Topics Covered
- 1 Executive Summary
- 1.1 Market Overview
- 2 Market Analysis
- 2.1 Analysis of Price Sensitivity, Lifecycle, Customer Purchase Basket, Adoption Rates, and Purchase Criteria
- 2.2 Criticality of Inputs and Factors of Differentiation
- 2.3 Factors of Disruption
- 2.4 Impact of Drivers and Challenges
- 3 Market Landscape
- 3.1 Market Ecosystem
- 3.2 Market Characteristics
- 3.3 Value Chain Analysis
- 4 Market Sizing
- 4.1 Market Definition
- 4.2 Market Segment Analysis
- 4.3 Market Size 2024
- 4.4 Market Outlook: Forecast for 2024-2029
- 5 Historic Market Size
- 5.1 Global AI In Remote Patient Monitoring Market 2019 - 2023
- 5.2 Component Segment Analysis 2019 - 2023
- 5.3 Indication Segment Analysis 2019 - 2023
- 5.4 End-user Segment Analysis 2019 - 2023
- 5.5 Geography Segment Analysis 2019 - 2023
- 5.6 Country Segment Analysis 2019 - 2023
- 6 Five Forces Analysis
- 6.1 Five Forces Summary
- 6.2 Bargaining Power of Buyers
- 6.3 Bargaining Power of Suppliers
- 6.4 Threat of New Entrants
- 6.5 Threat of Substitutes
- 6.6 Threat of Rivalry
- 6.7 Market Condition
- 7 Market Segmentation by Component
- 7.1 Market Segments
- 7.2 Comparison by Component
- 7.3 Solutions - Market Size and Forecast 2024-2029
- 7.4 Services - Market Size and Forecast 2024-2029
- 7.5 Market Opportunity by Component
- 8 Market Segmentation by Indication
- 8.1 Market Segments
- 8.2 Comparison by Indication
- 8.3 Cardiology - Market Size and Forecast 2024-2029
- 8.4 Diabetes - Market Size and Forecast 2024-2029
- 8.5 Neurology - Market Size and Forecast 2024-2029
- 8.6 Oncology - Market Size and Forecast 2024-2029
- 8.7 Others - Market Size and Forecast 2024-2029
- 8.8 Market Opportunity by Indication
- 9 Market Segmentation by End-user
- 9.1 Market Segments
- 9.2 Comparison by End-user
- 9.3 Hospitals - Market Size and Forecast 2024-2029
- 9.4 Home Healthcare Providers - Market Size and Forecast 2024-2029
- 9.5 Outpatient Clinics - Market Size and Forecast 2024-2029
- 9.6 Others - Market Size and Forecast 2024-2029
- 9.7 Market Opportunity by End-user
- 10 Customer Landscape
- 10.1 Customer Landscape Overview
- 11 Geographic Landscape
- 11.1 Geographic Segmentation
- 11.2 Geographic Comparison
- 11.3 North America - Market Size and Forecast 2024-2029
- 11.4 Europe - Market Size and Forecast 2024-2029
- 11.5 APAC - Market Size and Forecast 2024-2029
- 11.6 South America - Market Size and Forecast 2024-2029
- 11.7 Middle East and Africa - Market Size and Forecast 2024-2029
- 11.8 US - Market Size and Forecast 2024-2029
- 11.9 Germany - Market Size and Forecast 2024-2029
- 11.10 UK - Market Size and Forecast 2024-2029
- 11.11 China - Market Size and Forecast 2024-2029
- 11.12 Canada - Market Size and Forecast 2024-2029
- 11.13 Japan - Market Size and Forecast 2024-2029
- 11.14 France - Market Size and Forecast 2024-2029
- 11.15 India - Market Size and Forecast 2024-2029
- 11.16 Brazil - Market Size and Forecast 2024-2029
- 11.17 Spain - Market Size and Forecast 2024-2029
- 11.18 Market Opportunity By Geographical Landscape
- 12 Drivers, Challenges, and Opportunity/Restraints
- 12.1 Market Drivers
- 12.2 Market Challenges
- 12.3 Impact of Drivers and Challenges
- 12.4 Market Opportunities/Restraints
- 13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- 13.3 Landscape Disruption
- 13.4 Industry Risks
- 14 Competitive Analysis
- 14.1 Companies Profiled
- 14.2 Company Ranking Index
- 14.3 Market Positioning of Companies
- 14.4 Apple Inc.
- 14.5 Biofourmis Inc.
- 14.6 Boston Scientific Corp.
- 14.7 CareSimple
- 14.8 Current Health
- 14.9 GE Healthcare Technologies Inc.
- 14.10 Health Recovery Solutions
- 14.11 iRhythm Technologies Inc.
- 14.12 Koninklijke Philips NV
- 14.13 Medify Health
- 14.14 Medtronic Plc
- 14.15 ResMed Inc.
- 14.16 Siemens Healthineers AG
- 14.17 Validic
- 14.18 Vivify Health Inc.
- 15 Appendix
- 15.1 Scope of the Report
- 15.2 Inclusions and Exclusions Checklist
- 15.3 Currency Conversion Rates for US$
- 15.4 Research Methodology
- 15.5 Data Procurement
- 15.6 Data Validation
- 15.7 Validation Techniques Employed for Market Sizing
- 15.8 Data Synthesis
- 15.9 360 Degree Market Analysis
- 15.10 List of Abbreviations
For more information about this report visit https://www.researchandmarkets.com/r/a19ii3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
